LHC Group (LHCG) Earns “Hold” Rating from Robert W. Baird

Robert W. Baird restated their hold rating on shares of LHC Group (NASDAQ:LHCG) in a research report report published on Friday morning. They currently have a $69.00 target price on the health services provider’s stock.

A number of other research analysts also recently issued reports on LHCG. Jefferies Group LLC boosted their price target on LHC Group from $68.00 to $83.00 and gave the company a buy rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Royal Bank Of Canada boosted their price objective on LHC Group from $70.00 to $81.00 and gave the company an outperform rating in a research report on Tuesday, November 7th. Zacks Investment Research cut LHC Group from a buy rating to a hold rating in a research report on Friday. Oppenheimer Holdings, Inc. boosted their price objective on LHC Group from $68.00 to $80.00 and gave the company an outperform rating in a research report on Tuesday, November 7th. Finally, Craig Hallum restated a buy rating and issued a $80.00 price objective (up from $67.00) on shares of LHC Group in a research report on Tuesday, November 7th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $76.40.

Shares of LHC Group (LHCG) opened at $66.26 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a twelve month low of $41.66 and a twelve month high of $76.14. The company has a market capitalization of $1,211.21, a PE ratio of 28.44, a P/E/G ratio of 1.96 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The company had revenue of $272.90 million during the quarter, compared to the consensus estimate of $265.35 million. During the same period in the previous year, the company posted $0.54 earnings per share. LHC Group’s revenue for the quarter was up 18.2% on a year-over-year basis. analysts expect that LHC Group will post 2.4 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.chaffeybreeze.com/2017/11/13/lhc-group-lhcg-earns-hold-rating-from-robert-w-baird.html.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 14.80% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of LHCG. UBS Asset Management Americas Inc. purchased a new stake in LHC Group in the 1st quarter valued at $248,000. Principal Financial Group Inc. lifted its stake in shares of LHC Group by 3.6% in the 1st quarter. Principal Financial Group Inc. now owns 113,707 shares of the health services provider’s stock valued at $6,129,000 after purchasing an additional 3,983 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of LHC Group by 1.2% in the 1st quarter. Legal & General Group Plc now owns 25,087 shares of the health services provider’s stock valued at $1,353,000 after purchasing an additional 290 shares during the last quarter. Thrivent Financial For Lutherans lifted its stake in shares of LHC Group by 4.1% in the 1st quarter. Thrivent Financial For Lutherans now owns 8,380 shares of the health services provider’s stock valued at $452,000 after purchasing an additional 330 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of LHC Group by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock valued at $77,185,000 after purchasing an additional 54,279 shares during the last quarter. Institutional investors own 87.29% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply